https://statnews.com

STAT | Reporting from the frontiers of health and medicineYour go-to source for the latest news in health, science and medicine. Sign up for STAT+ for exclusive analysis of biotech, pharma, and the life sciences.STAT | Reporting from the frontiers of health and medicine Skip to Main Content Explore what it takes to make the health care system work. Cancer Vaccines research Explore what it takes to make the health care system work. Newsletters Log In My Account Subscribe Now My Account Settings Billing Log Out Reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now BiotechPharmaPublic HealthHealth TechPolicyScienceFirst OpinionSTAT+STAT Events Search Log In Try STAT+ My Account Home News Latest Business Biotech Pharma Health Tech Health Insurance Hospitals Medical Devices Washington Policy FDA CDC NIH Science CRISPR Gene Therapy Research Neuroscience Public Health H5N1 Bird Flu Addiction Covid-19 Abortion Health Disparities Infectious Disease Mental Health Disease Cancer Cardiovascular Disease Chronic Disease Diabetes Alzheimer's Obesity Features Coercive Care The Obesity Revolution The War on Recovery Newsletters Opinion Columns Adam Feuerstein Matthew Herper Jennifer Adaeze Okwerekwu Ed Silverman Reports E-books Podcasts Tools & Trackers CRISPR Tracker Breakthrough Device Tracker Generative AI Tracker Obesity Drug Tracker Events 2024 STAT Summit All Summits Community STATUS List STAT Madness Video Advertise STAT Brand Studio Don't miss out Subscribe to STAT+ today, for the best life sciences journalism in the industry Learn more STAT — Reporting from the frontiers of health and medicine Latest September 27, 2024 Four more health care workers reported illnesses after caring for bird flu case in Missouri September 27, 2024 WHO director general: A breakthrough global agreement on combatting antimicrobial resistance September 27, 2024 STAT Plus: Regeneron, Sanofi blockbuster Dupixent wins FDA approval for COPD September 27, 2024 Why are Genentech cancer researchers worried? September 27, 2024 Sequencing wastewater material may be the key to getting a grip on the H5N1 bird flu outbreak September 27, 2024 STAT Plus: Q&A: MedStar Health’s Raj Ratwani on health AI and the battle raging over regulation More Stories Don't Miss Explore the harm race-based clinical algorithms can cause Discover the series Top Stories Health Sickle cell community scrambles to find safe plan after a drug is pulled from the market Everyone was caught between two possibilities: Taking the drug might put patients at risk, but abruptly stopping the drug could put patients at risk, too By Eric Boodman September 27, 2024 chronic disease Pfizer Pharmaceuticals By Eric Boodman Health tech Health tech September 26, 2024 STAT Plus: Epic Systems has been challenged in court before, but it’s different this time By Casey Ross Health Health September 27, 2024 Dispute over Duchenne gene therapy highlights thorny access issues By Andrew Joseph Pharma Pharma September 26, 2024 STAT Plus: FDA approves schizophrenia drug that could alter how disorder is treated By Adam Feuerstein Pharma Pharma September 26, 2024 STAT Plus: What the withdrawal of its sickle cell drug means for Pfizer, patients, and the FDA By Matthew Herper, Eric Boodman, Andrew Joseph, Lizzy Lawrence, Adam Feuerstein, and Jason Mast Most Read Health HPV vaccine, cervical cancer study delivers historic results 1 of 5 most read today Health After caring for bird flu case in Missouri, 4 more health care workers fell ill 2 of 5 most read today Health Fauci recovering at home following hospitalization for West Nile virus infection 3 of 5 most read today Health Healthy food access boosts outcomes in two studies 4 of 5 most read today Health Food is medicine: Medicaid contractors delivering salty, fatty foods 5 of 5 most read today Most Read In STAT+ Matt's Take STAT Plus: Can 23andMe, at yet another crossroads, be saved again by Anne Wojcicki? 1 of 5 most read today Pharma STAT Plus: FDA approves Bristol schizophrenia drug that could alter how disorder is treated 2 of 5 most read today Pharma STAT Plus: Pfizer decision to withdrawal sickle cell drug leaves patients, advocates reeling 3 of 5 most read today Business STAT Plus: Humana reduces 2025 Medicare Advantage plan offerings 4 of 5 most read today Biotech STAT Plus: ARCH Venture Partners, a biotech VC, raises $3 billion for a new fund 5 of 5 most read today Sponsored Advertisement Newsletters The Readout Why are Genentech cancer researchers worried? D.C. Diagnosis STAT Plus: Medicare will continue its cautious approach to paying for Alzheimer’s drugs The Readout Biotech’s real estate market is still upside down Sign up for Newsletters STAT+ Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now. Cancel anytime. Subscribe now Trending Now All STAT+ Stories STAT Plus: What the withdrawal of its sickle cell drug means for Pfizer, patients, and the FDA STAT Plus: FDA approves schizophrenia drug that could alter how disorder is treated STAT Plus: Can Anne Wojcicki save 23andMe? STAT Plus: The little-known Chinese biotech whose cancer drug beat Keytruda has global ambitions STAT Plus: ARCH Venture Partners raises $3 billion for a new biotech fund All STAT+ Stories All Events More From STAT More From STAT More From STAT Events STAT offers a variety of in-person and virtual events throughout the year. All Events 16 Oct 2024 STAT Summit Boston, MA October 16, 2024 Join us in Boston or virtually October 16 – 17 at the 2024 STAT Summit for discussions on the latest breakthroughs in health & medicine. All Events All Trackers More From STAT More From STAT More From STAT Trackers We create tools to help you understand and track complex areas of development. All Trackers Obesity Drug Tracker Here are the dozens of weight loss drugs in development to catch a booming market. CRISPR Tracker Follow the latest developments in genome editing. Generative AI Tracker A guide to the health systems and companies driving adoption. Breakthrough Device Tracker An authoritative database of FDA’s fast-tracked medical devices. All Reports More From STAT More From STAT More From STAT Reports STAT Reports blend data insights with qualitative observations on pivotal life sciences topics. All Reports STAT’s guide to interpreting clinical trial results $49 Our bestselling report is now updated to help you read clinical trial results with an appropriately skeptical (or critical) eye. Targeting cancer: the new frontier of immunotherapy and precision oncology A new generation of drugs is transforming the way scientists think about the illness. Ranking biotech’s top venture capital firms Interpreting clinical trial results is not for the faint of heart… All Podcasts More From STAT More From STAT More From STAT Podcasts From policy to practice: STAT's podcasts decode health care complexities. All Podcasts The Readout LOUD Our weekly biotech podcast digs deep into industry goings-on. First Opinion Podcast Our opinion podcast discusses the people, issues, and ideas that are shaping health care. Color Code Our podcast raising the alarm on racial inequities in American health care. More From STAT Events Trackers Reports Podcasts More Stories Latest Most Read Subscriber Only Opinion Health Health September 27, 2024 Four more health care workers reported illnesses after caring for bird flu case in Missouri By Helen Branswell • September 27, 2024 First Opinion First Opinion September 27, 2024 WHO director general: A breakthrough global agreement on combatting antimicrobial resistance By Tedros Adhanom Ghebreyesus • September 27, 2024 Biotech Biotech September 27, 2024 STAT Plus: Regeneron, Sanofi blockbuster Dupixent wins FDA approval for COPD By Jonathan Wosen • September 27, 2024 The Readout The Readout September 27, 2024 Why are Genentech cancer researchers worried? By Meghana Keshavan • September 27, 2024 First Opinion First Opinion September 27, 2024 Sequencing wastewater material may be the key to getting a grip on the H5N1 bird flu outbreak By Ranu Dhillon, Abraar Karan, and Devabhaktuni Srikrishna • September 27, 2024 Health tech Health tech September 27, 2024 STAT Plus: Q&A: MedStar Health’s Raj Ratwani on health AI and the battle raging over regulation By Brittany Trang • September 27, 2024 Biotech Biotech September 26, 2024 STAT Plus: Cassava Sciences and former execs, facing SEC charges for misleading claims, agree to fines By Jonathan Wosen • September 26, 2024 D.C. Diagnosis D.C. Diagnosis September 26, 2024 STAT Plus: Medicare will continue its cautious approach to paying for Alzheimer’s drugs By Rachel Cohrs Zhang • September 26, 2024 Politics Politics September 26, 2024 STAT Plus: Hassan indicates she’s open to tweaks on site-neutral payment reforms By John Wilkerson and Rachel Cohrs Zhang • September 26, 2024 Politics Politics September 26, 2024 STAT Plus: Biden administration axes proposal to mandate more drug price transparency in Medicaid By Bob Herman • September 26, 2024 Politics Politics September 26, 2024 STAT Plus: FDA introduces plan to assess safety of common chemicals added to food By Lizzy Lawrence • September 26, 2024 Politics Politics September 26, 2024 STAT Plus: Head of national stockpile addresses Congress’ criticisms of outbreak response By Isabella Cueto • September 26, 2024 Hospitals Hospitals September 26, 2024 STAT Plus: Two reports, two dramatically different views of nonprofit hospitals’ tax breaks By Tara Bannow • September 26, 2024 All Stories Health Health September 4, 2024 Trying to time your vaccines just right? There are no easy answers, but here are some factors to consider By Helen Branswell • September 4, 2024 Health Health September 25, 2024 Can MRIs ensure prostate cancer screening does more good than harm? By Angus Chen • September 25, 2024 Health Health September 27, 2024 Dispute over Duchenne gene therapy highlights thorny access issues By Andrew Joseph • September 27, 2024 Politics Politics September 26, 2024 STAT Plus: Biden administration axes proposal to mandate more drug price transparency in Medicaid By Bob Herman • September 26, 2024 Biotech Biotech September 3, 2024 STAT Plus: Recursion presents mixed data on lead AI-derived drug candidate for potentially fatal brain condition By Allison DeAngelis • September 3, 2024 Pharmalot Pharmalot September 27, 2024 STAT Plus: Up and down the ladder: The latest comings and goings By Ed Silverman • September 27, 2024 Pharmalot Pharmalot September 27, 2024 STAT Plus: Pharmalittle: We’re reading about a new schizophrenia drug, a U.N. pledge on AMR and more By Ed Silverman • September 27, 2024 Pharmalot Pharmalot September 26, 2024 STAT Plus: Pharmalittle: We’re reading about Pfizer pulling a sickle cell pill, Moderna getting scolded, and more By Ed Silverman • September 26, 2024 Biotech Biotech September 26, 2024 STAT Plus: AbbVie Parkinson’s drug helps improve symptoms in late-stage study By Elaine Chen • September 26, 2024 Biotech Biotech September 26, 2024 STAT Plus: ARCH Venture Partners raises $3 billion for a new biotech fund By Allison DeAngelis • September 26, 2024 Adam's Take Adam's Take September 26, 2024 STAT Plus: Why Biohaven will test the FDA’s regulatory limits   By Adam Feuerstein • September 26, 2024 First Opinion First Opinion September 27, 2024 WHO director general: A breakthrough global agreement on combatting antimicrobial resistance By Tedros Adhanom Ghebreyesus • September 27, 2024 First Opinion First Opinion September 27, 2024 Sequencing wastewater material may be the key to getting a grip on the H5N1 bird flu outbreak By Ranu Dhillon, Abraar Karan, and Devabhaktuni Srikrishna • September 27, 2024 Adam's Take Adam's Take September 26, 2024 STAT Plus: Why Biohaven will test the FDA’s regulatory limits   By Adam Feuerstein • September 26, 2024 Adam's Take Adam's Take September 26, 2024 STAT Plus: Gene therapy for sickle cell disease remains a tough business model — and may never work By Adam Feuerstein • September 26, 2024 First Opinion First Opinion September 26, 2024 Congress must reauthorize the Older Americans Act to keep seniors safe from heat By Marquisha Johns and Casey Doherty • September 26, 2024 Matt's Take Matt's Take September 25, 2024 STAT Plus: Can Anne Wojcicki save 23andMe? By Matthew Herper • September 25, 2024 Newsletters Mon - Fri Your daily dose of news in health and science Please enter a valid email address. I'd like to be emailed about new content, events, and products. Our Picks Our Picks Our Picks STAT’s selection of must-read stories and investigations STAT Plus: Can Anne Wojcicki save 23andMe? By Matthew Herper STAT Plus: The little-known Chinese biotech whose cancer drug beat Keytruda has global ambitions By Jonathan Wosen How I fought Big Pharma on insulin prices — and won By Elizabeth Pfiester Millions of Americans want to quit smoking. Critics say drugmakers and the FDA are failing them By Nicholas Florko STAT Plus: 12 people shaping psychedelics drug development By Meghana Keshavan A failing health care system caused my husband’s death By Vonda Vaden Bates STAT Plus: Inside the quiet strategy pharma giants are using to fend off generics and drive up the cost of medicines By Ed Silverman and Michael Nolan STAT Plus: A new cell therapy company takes its vision from four founders, and its skin from George Church By Allison DeAngelis Biotech Biotech STAT Plus: Pfizer pulls sickle cell treatment Oxbryta off global markets By Adam Feuerstein and Jason Mast September 25, 2024 By Adam Feuerstein and Jason Mast Biotech Biotech September 25, 2024 STAT Plus: Pfizer pulls sickle cell treatment Oxbryta off global markets Biotech Biotech September 25, 2024 STAT Plus: Celldex drug reduces chronic hive activity, but patient discontinuations raise questions Biotech Biotech September 24, 2024 STAT Plus: Amgen scores late-stage trial success for eczema and myasthenia gravis treatments, but faces stiff competition Pharma Pharmalot STAT Plus: Moderna is scolded by a U.K. trade group for offering kids $2,000 to participate in a Covid trial By Ed Silverman September 25, 2024 By Ed Silverman Pharmalot Pharmalot September 25, 2024 STAT Plus: Moderna is scolded by a U.K. trade group for offering kids $2,000 to participate in a Covid trial Pharmalot Pharmalot September 25, 2024 STAT Plus: Pharmalittle: We’re reading about Sanders and Novo Nordisk CEO sparring, Roche refocusing, and more Pharmalot Pharmalot September 24, 2024 STAT Plus: Baltimore claims Biogen ‘bribed’ PBMs to favor its pricey MS drug over generics Health Health The FDA is ‘making sandwiches,’ ‘breakfast salad’ in DC, and what keeps us from choking on food By Brittany Trang September 27, 2024 By Brittany Trang Health Health September 27, 2024 The FDA is ‘making sandwiches,’ ‘breakfast salad’ in DC, and what keeps us from choking on food Health Health September 26, 2024 Higher buprenorphine doses prevent hospitalization of people with fentanyl addiction, study finds Health Health September 25, 2024 Ozempic linked to lower opioid overdose rate in those with diabetes, study shows Politics Politics STAT Plus: Sanders says PBMs won’t penalize Novo for cutting Ozempic, Wegovy prices By Rachel Cohrs Zhang and Elaine Chen September 24, 2024 By Rachel Cohrs Zhang and Elaine Chen Politics Politics September 24, 2024 STAT Plus: Sanders says PBMs won’t penalize Novo for cutting Ozempic, Wegovy prices Politics Politics September 24, 2024 STAT Plus: The U.S. has relied on cheap, effective generic drugs for 40 years. Now that promise is under threat Politics Politics September 23, 2024 STAT Plus: Wegovy is among drugs set to be targeted in the next round of Medicare price negotiations, researchers say Video Health A history of mpox so far Video STAT Plus: The little-known bill that made drugs more affordable Video Why clinicians are reconsidering race-based algorithms Video STAT Plus: How drug patents pave the way to profit All Videos EXCLUSIVEEXCLUSIVE We have a deep pipeline that goes beyond ivonescimab. And we definitely want to position Akeso as a global biotech, not just a China story.Read the story — Bing Wang, chief financial officer of Akeso, whose drug ivonescimab decisively beat Keytruda in late-stage lung cancer trials EXCLUSIVE Health tech Health tech STAT Plus: Sleep apnea alert on Apple Watch: What does it mean, and how does it work? By Mario Aguilar September 26, 2024 By Mario Aguilar Health tech Health tech September 26, 2024 STAT Plus: Sleep apnea alert on Apple Watch: What does it mean, and how does it work? Health tech Health tech September 24, 2024 STAT Plus: Can AI reduce health care fraud, AI firm in Texas AG’s crosshairs, and more Health tech Health tech September 24, 2024 STAT Plus: As Medicare spending on remote patient monitoring jumps, HHS watchdog warns of fraud, misuse In the Lab In the Lab STAT Plus: Q&A: How scientists aim to kill cancers by starving them By Angus Chen September 20, 2024 By Angus Chen In the Lab In the Lab September 20, 2024 STAT Plus: Q&A: How scientists aim to kill cancers by starving them In the Lab In the Lab September 20, 2024 STAT Plus: Research misconduct claims are growing. Will new rules help universities investigate? In the Lab In the Lab September 19, 2024 Long-overlooked scientist shares Lasker Award with other GLP-1 researchers Hospitals Hospitals STAT Plus: Ascension, other hospitals played active roles to take medical billing company R1 RCM private By Bob Herman September 6, 2024 By Bob Herman Hospitals Hospitals September 6, 2024 STAT Plus: Ascension, other hospitals played active roles to take medical billing company R1 RCM private Hospitals Hospitals September 3, 2024 STAT Plus: Dana-Farber CEO Laurie Glimcher to step down, saying ‘we must look to the next generation’ Hospitals Hospitals August 15, 2024 STAT Plus: UnitedHealthcare’s latest contract dispute, this time with Trinity Health, leaves thousands out-of-network  Insurance Insurance STAT Plus: Insurers went all-in on Medicare Advantage. Now, some are scaling back  By Tara Bannow September 13, 2024 By Tara Bannow Insurance Insurance September 13, 2024 STAT Plus: Insurers went all-in on Medicare Advantage. Now, some are scaling back  Insurance Insurance September 10, 2024 STAT Plus: Elevance buys IU Health’s insurance company Insurance Insurance August 7, 2024 STAT Plus: CVS removes top Aetna leader as higher medical costs eat further into profits Podcasts The Readout LOUD Genentech’s cancer pivot, Pfizer’s sickle cell withdrawal, and a new schizophrenia drug The Readout LOUD Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates The Readout LOUD A new threat to Merck’s blockbuster cancer treatment, Moderna’s cutbacks, and obesity drugs for kids The Readout LOUD Summit’s upcoming cancer results, Recursion’s mixed data, and a new co-host All Podcasts Sign up for our morning rounds newsletter Reporting from the frontiers of health and medicine Back to top Company About Our Team Contact Us Careers Diversity & Inclusion Our Awards Advertise With Us STAT Brand Studio Supporters Licensing Stories Account STAT+ Group Subscriptions FAQ My Account Log In Subscribe More Events Newsletters Reports App Podcasts Community Privacy Comment Policy Terms Do Not Sell My Data ©2024 STATenusen-US1727613668https://statnews.com

ཁྱོད་རའི་ས་ཁོངས་ཞུན་དག་འབད་ག?

ཁྱོད༌ག༌ཅི༌འབདཝ༌སྨོ?